Prevalence and Determinants of High-risk Human Papillomavirus Infection in Women with High Socioeconomic Status in Seoul, Republic of Korea

Similar documents
Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

The Korean Journal of Cytopathology 15 (1) : 17-27, 2004

Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea

Cytomorphologic Features According to HPV DNA Type in Histologically Proven Cases of the Uterine Cervix

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Making Sense of Cervical Cancer Screening

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Clinical Practice Guidelines June 2013

HPV & CERVICAL CANCER POLICY & LEGISLATIVE TOOLKIT, 3 RD EDITION

Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?

No HPV High Risk Screening with Genotyping. CPT Code: If Result is NOT DETECTED (x3) If Results is DETECTED (Genotype reported)

I have no financial interests in any product I will discuss today.

Title: Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women

Yuanyuan Wang, 1 Shaohong Wang, 1 Jinhui Shen, 1 Yanyan Peng, 2 Lechuan Chen, 2 Ruiqin Mai, 3 and Guohong Zhang Introduction

Eradicating Mortality from Cervical Cancer

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

PAP smear. (Papanicolaou Test)

Effect of human papillomavirus genotype on severity and prognosis of cervical intraepithelial neoplasia

BRITISH COLUMBIA S CERVICAL CANCER SCREENING PROGRAM

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Understanding Your Pap Test Results

Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA

RESEARCH ARTICLE. Yue-Yun Wang 1, Li Li 2, Sheng Wei 2, Ji Peng 3, Shi-Xin Yuan 1, Jian-Sheng Xie 1, Zhi-Hua Liu 1 * Abstract.

The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study

Objectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies

The ATHENA HPV study underrepresents other high-risk HPV genotypes when compared with a diverse New York City population

FREQUENCY AND RISK FACTORS OF CERVICAL Human papilloma virus INFECTION

Cost-effectiveness Analysis of Cervical Cancer Screening Strategies Based on the Papanicolaou Smear Test in Korea

I have no financial interests in any product I will discuss today.

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Pathology of the Cervix

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer

News. Laboratory NEW GUIDELINES DEMONSTRATE GREATER ROLE FOR HPV TESTING IN CERVICAL CANCER SCREENING TIMOTHY UPHOFF, PHD, DABMG, MLS (ASCP) CM

BC Cancer Cervix Screening 2015 Program Results. February 2018

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

Focus. International #52. HPV infection in High-risk HPV and cervical cancer. HPV: Clinical aspects. Natural history of HPV infection

Banghyun Lee 1, Hye-Yon Cho 2, Kum Jin Jeon 1, Kidong Kim 1,3, Jung Ryeol Lee 1,3, Jung Joo Moon 4, Jae Hong No 1,3 and Yong-Beom Kim 1,3.

HPV AND CERVICAL CANCER

Human Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?

Absolute Risk of a Subsequent Abnormal Pap among Oncogenic Human Papillomavirus DNA-Positive, Cytologically Negative Women

- ii - Rights c

Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Human Papillomavirus

TISSUE TUMOR MARKER EXPRESSION IN

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

The promise of HPV vaccines for Cervical (and other genital cancer) prevention

Smoking, human papillomavirus infection, and p53 mutation as risk factors in oropharyngeal cancer: a case-control study

The society for lower genital tract disorders since 1964.

HUMAN PAPILLOMAVIRUS TESTING

Cervical Cancer Screening - Improving PAP Rates. Objectives

AGC Subclasses and Risk of Invasive Cancers

Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix

Performance of the Aptima High-Risk Human Papillomavirus mrna Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology

Cervical Cancer Screening

RESEARCH COMMUNICATION

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index

Human Papillomavirus Prevalence, Viral Load and Cervical Intraepithelial Neoplasia in HIV-Infected Women

Epidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China: a cross-sectional five years study in non-vaccinated women

ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way

Colposcopy. Attila L Major, MD, PhD

A Case-Control Study of Risk Factors for Invasive Cervical Cancer among U.S. Women Exposed to Oncogenic Types of Human Papillomavirus

European Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs

INTRODUCTION HUMAN PAPILLOMAVIRUS

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests

Clinical Performance of Roche COBAS 4800 HPV Test

Should Anal Pap Smears Be a Standard of Care in HIV Management?

Pap plus HPV every 3 years with screening stopped at 65, 75 and 100 years; Pap plus HPV every 2 years with screening stopped at 65, 75 and 100 years.

Original Policy Date

Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women

Screening for Cervical Cancer. Grand Rounds 1/16/13 Meggan Linck

Clinical Relevance of HPV Genotyping. A New Dimension In Human Papillomavirus Testing. w w w. a u t o g e n o m i c s. c o m

Factors associated with HPV persistence after conization in patients with negative margins

Cervical Cancer Screening. David Quinlan December 2013

Human Papillomavirus Genotypes and the Cumulative 2-Year Risk of Cervical Precancer

Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women

chapter 4. The effect of oncogenic HPV on transformation zone epithelium

The devil is in the details

Epidemiologic characteristics of cervical cancer in Korean women

EXPERIMENTAL AND THERAPEUTIC MEDICINE 13: , 2017

Objectives. Background. Background. Background. Background 9/26/16. Update on Cervical and HPV Screening Guidelines: To pap or not to pap?

Human papillomavirus and vaccination for cervical cancer

High-risk Human Papillomavirus Infection in Low Risk Women: Incidence, Patient Characteristics, and Clinical Meaning for Cervical Cancer

The impact of the HPV vaccine in Scotland.

Prevalence of cervical human papillomavirus infection and types among women immigrated to Sicily, Italy

Safe, Confident, QIAsure

Gynecologic Oncology

Natural History of HPV Infections 15/06/2015. Squamous cell carcinoma Adenocarcinoma

PATTERN AND FACTORS AFFECTING PAP SMEAR TEST IN NABLUS, A RETROSPECTIVE STUDY

Pushing the Boundaries of the Lab Diagnosis in Asia

ANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION

An Update on Cervical Cancer Screening Recommendations and on the DOH BCC Program

Biomed Environ Sci, 2015; 28(1): 80-84

Genital prevalence of HPV types and co-infection in men

Human Papillomavirus. Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita

Transcription:

RESEARCH COMMUNICATION Prevalence and Determinants of High-risk Human Papillomavirus Infection in Women with High Socioeconomic Status in Seoul, Republic of Korea Kidong Kim 1, Jin Ju Kim 2,3, Sun Mie Kim 2,3, Jae Hong No 1, Yong-Beom Kim 1 * Abstract We aimed to estimate the prevalence of high-risk human papillomavirus (HPV) infections in women of high socioeconomic status (SES) in Seoul, Republic of Korea and to identify risk factors. This study included 13,386 women visiting a prestigious healthcare center located in Seoul between 2003 and 2008. High-risk HPV infections were detected in 994 (7%) and the age-standardized prevalence was 8%. Abnormal Pap smear results atypical squamous cells of unknown significance (ASCUS) were observed in 280 of 12,080 women (2%). Based on univariate analysis, age, level of education and number of children were associated with high-risk HPV infections. Based on multivariate analysis, age and high-risk HPV infections had an inverse relationship. In women with high SES in Seoul, the prevalence of high-risk HPV infection was 7% and the age-standardized prevalence was 8%. Age was a strong determinant of high-risk HPV infection. Key words: Human papillomavirus - papillomavirus infection - prevalence - social class - age factor - Korea Asian Pacific J Cancer Prev, 13, 269-273 Introduction Cervical cancer is one of the most common malignancies and the leading cause of cancer-related deaths in females worldwide (Kim, 2009). For example, there were 529,800 new cervical cancer cases and 275,100 deaths due to cervical cancer worldwide in 2008 (Jemal et al., 2011). Human papillomavirus (HPV) is the primary cause of cervical cancer and > 100 types of HPV have been identified (Kim, 2009). HPVs are classified as high- or low-risk types based on oncogenicity (de Villiers et al., 2004), and numerous studies have shown that high-risk HPV infections are an independent risk factor for cervical cancer (Bosch et al., 1995). Recently, HPV vaccines were developed and showed promising efficacy in preventing high-risk HPV infections and cervical pre-cancerous diseases [1]. To estimate the cost and benefit of implementation of HPV vaccines, knowledge of the prevalence and risk factors for high-risk HPV infections is critical. Previous studies have demonstrated that the prevalence of HPV varies according to region and socioeconomic status (SES) (Clifford et al., 2003; 2005; Kahn et al., 2007; Bao et al., 2008; Silva et al., 2009). Therefore, the prevalence of HPV according to region and SES are necessary to estimate the impact of implementation of HPV vaccines. The prevalence of HPV in Korean women has been investigated in several studies (Bae et al., 2008; Kim, 2009). However, most studies have not specified the region involved, and studies including women in Seoul are still insufficient, considering the population size of Seoul over ten million. Furthermore, there are no studies investigating the prevalence of HPV in women with low or high SES. The aims of this study were to estimate the prevalence of high-risk HPV infections in women with high SES who underwent a health check-up at a prestigious healthcare center in Seoul and to identify risk factors for high-risk HPV infections. Materials and Methods The Population This study included women visiting a healthcare center located in the Gangnam area of Seoul, Republic of Korea between 2003 and 2008. The healthcare center is a branch of a university hospital and performs approximately 50000 health evaluations per year. After acquiring the approval of the Institutional Review Board (B-1104-125-110), all women visiting the healthcare center between 2003 and 2008 were identified. Women who did not undergo a HPV test (Hybrid Capture 1 Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam-Si, 2 Department of Obstetrics and Gynecology, Seoul National University College of Medicine, 3 Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Republic of Korea *For correspondence: ybkimlh@snubh.org Asian Pacific Journal of Cancer Prevention, Vol 13, 2012 269

K Kim et al 2; Digene Corporation, Inc., Gaithersburg, Maryland, USA) or did not have an intact cervix were excluded. Women who had other HPV tests, such as the DNA chip test, were also excluded. Health evaluation Two or three weeks before a health evaluation, a structured questionnaire was sent to the women who had made an appointment. The questionnaire included questions regarding demographic and socioeconomic variables, medical history, and current symptoms. Return of the self-completed questionnaire was requested before the health evaluation and the contents of the questionnaire were input into a database by data managers. At the health evaluation, a gynecologist performed a pelvic examination and obtained a specimen for the HPV test from the cervix using a cervical sampler. On the day of collection, the specimens were sent to the Department of Laboratory Medicine in the healthcare center and analyzed. In most cases, a Papanicolau (Pap) smear was also performed before the HPV test because most of the health evaluation programs included both tests. HPV test To detect high-risk HPV infections, the Hybrid Capture 2 (HC2) test was performed according to the manufacturer s instructions. The specific procedures of the HC2 test have been described in numerous studies (Nam et al., 2009). The results of the HC2 test were reported as positive or negative for high-risk HPV infections (HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68). Variables The HPV test results, age, Pap smear results, smoking history, level of education, monthly income, number of children, and age at first delivery were extracted from the healthcare center database. In women who had the HPV test more than once during the study period, the data at the time of the first HPV test were obtained. The unit of monthly income was converted from Korean won to US dollars using an exchange rate of 1$ = 1100 won. Statistical analysis The age-standardized prevalence of high-risk HPV infections was calculated using the age distribution of Korean women in 2000. To estimate the association of variables with high-risk HPV infections, the values of each variable were categorized appropriately or using quantile values. The prevalence and odds ratio (OR) with 95% confidence interval (CI) for high-risk HPV infections according to categorized variables were calculated using unadjusted logistic regression analysis. In addition, for ordinal variables, analyses were performed using a chi-square test or linear-by-linear association method. Variables which were associated with high-risk HPV 270 Asian Pacific Journal of Cancer Prevention, Vol 13, 2012 Table 1. Association of Age with High-risk HPV Infection 29 211 25 11 1 <0.01 30-39 2142 214 9 0.8 (0.5-1.3) 40-49 4329 418 9 0.8 (0.5-1.2) 50-59 4060 247 6 0.5 (0.3-0.8) 60-69 1477 83 5 0.5 (0.3-0.8) 70 173 7 4 0.3 (0.1-0.8) Table 2. Association of Pap Smear Results with High-risk HPV Infections Pap HPV- % of OR (95% CI) Normal 11070 730 6 1 ASCUS 60 59 50 14.9 (10.3-21.5) AGC-NOS 5 2 29 6.1 (1.2-31.3) LSIL 26 74 74 43.2 (27.4-67-9) ASC-H 6 10 63 25.3 (9.2-69.7) HSIL 4 27 87 102.4 (35.7-293.3) AGC-N 1 1 50 15.2 (0.9-242.7) Cancer 1 4 80 60.7 (6.8-543.4) ASCUS, atypical squamous cells of unknown significance; AGC-NOS, atypical glandular cells not otherwise specified; LSIL, low-grade squamous intraepithelial lesion; ASC-H, atypical squamous cells cannot exclude HSIL; HSIL, highgrade squamous intraepithelial lesion; AGC-N, atypical glandular cells favor neoplastic Table 3. Association of smoking-related Variables with High-risk HPV Infections Age HPV- % of OR (95% CI) P for Smoking - Never 8597 689 7 1 Ever 956 91 9 1.2 (0.9-1.5) Former 418 42 9 1.3 (0.9-1.7) Current 538 49 8 1.1 (0.8-1.5) Age of smoking onset, year 20 83 11 12 1 21-25 89 8 8 0.7 (0.3-1.8) 26 80 6 7 0.6 (0.2-1.6) Pack-years 1.0 183 22 11 1 1.1-3.6 170 19 10 0.9 (0.5-1.8) 3.7-7.5 194 17 8 0.7 (0.4-1.4) 7.6 177 21 11 1 (0.5-1.9) infections in univariate analysis were dichotomized appropriately or using median values. The dichotomized variables were included in the binary logistic regression analysis to identify the independent risk factors for high-risk HPV infection. SPSS version 18.0 (IBM Corporation, Somers, NY, USA) and P value < 0.05 was used to determine the statistical significance. Results HPV prevalence and baseline characteristics A total of 13,386 women were included in this study

Table 4. Association of Socioeconomic Variables with High-risk HPV Infections Level of education 0.01 Primary 902 50 5 1 Middle 352 25 7 1.3 (0.8-2.1) High 2637 221 8 1.5 (1.1-2.1) College or 4834 396 8 1.5 (1.1-2.0) university Graduate 1387 125 8 1.6 (1.2-2.3) Monthly income, USD < 2727 1060 66 6 1 2727 1846 154 8 1.3 (1.0-1.8) 4545 4545 1968 170 8 1.4 (1.0-1.9) - 7273 7273 1290 109 8 1.4 (1.0-1.9) - 9091 9191 1245 100 7 1.3 (0.9-1.8) - 13636 13636 462 37 7 1.3 (0.8-2.0) - 18182 > 18182 897 83 9 1.5 (1.1-2.1) Table 5. Association between Obstetric Variables and High-risk HPV Infections No. of children <0.01 0 815 92 10 1 1 1190 104 8 0.8 (0.6-1.0) 2 5356 419 7 0.7 (0.5-0.9) 3 1967 160 8 0.7 (0.6-0.9) > 3 719 36 5 0.4 (0.3-0.7) Age at first delivery, years 24 2322 186 7 1 25-26 2625 196 7 0.9 (0.8-1.1) 27-28 2169 161 7 0.9 (0.7-1.2) 29 1968 161 8 1 (0.8-1.3) Table 6. Association between Variables and High- Risk HPV Infections based on Multivariate Analysis Variable P OR (95% CI) Age 48 vs. > 48 <0.01 0.5 (0.5-0.6) Level of education High vs. 0.9 (0.8-1.1) > High No. of children 2 vs. > 2 1.1 (0.9-1.3) and high-risk HPV infection was detected in 994 women (7%). The age-standardized prevalence of high-risk HPV infection was 8%. The median age was 48 years. Abnormal Pap smear results (atypical squamous cells of unknown significance [ASCUS] or more severe cytologic changes) were observed in 280 of 12080 women (2%) who had Pap smears. Ever-smoking was reported in 956 of 9553 women (10%) who responded. The median age when women started smoking was 23 years and the median number of pack-years was four. Education beyond high was reported in 6221 of 10112 women (62%) who responded. The median monthly income was 4545-7273 USD. The median number of children was two, and the median age at the time of the first delivery was 26 years. Association of variables with high-risk HPV infections Age and high-risk HPV infections had an inverse relationship. For example, women > 50 had a significantly lower prevalence of high-risk HPV infections than women < 30 years of age (Table 1). Women with abnormal Pap smear results had a higher prevalence of high-risk HPV infections than women with normal Pap smear results (Table 2). Ever-smoking, age of smoking onset, and pack-years of smoking was not associated with high-risk HPV infections (Table 3). The level of education had a positive relationship with high-risk HPV infections. For example, women who graduated from high or more had a higher prevalence of high-risk HPV infection than women who only completed primary (Table 4). The monthly income was not associated with high-risk HPV infections (Table 4). The number of children and high-risk HPV infections had an inverse relationship. To explain further, women who had two or more children had a lower prevalence of high-risk HPV infection than women without a child (Table 5). However, the age at the time of first delivery was not associated with high-risk HPV infections (Table 5). Based on multivariate analysis, age was associated with high-risk HPV infections, but neither the level of education nor the number of children was associated with high-risk HPV infections (Table 6). Discussion The women in the current study were older, more educated, and had higher monthly income than the average woman in Seoul or Korea. Specifically, the median age of women included in this study was 48 years, but the median age of all women in Seoul was 35 years in 2005 (Korea Statistical Information Service, 2011). The percentage of women who had abnormal Pap smear results (ASCUS or more severe cytologic features) in the current study (2%) was similar to other studies involving Korean women. For example, a study including 3091 women visiting a healthcare center in Seoul reported abnormal Pap smear results in 2% of women (Joo et al, 2004). Another study including 4595 women participating in the National Cervical Cancer Screening Program in Busan and Suwon showed a 3% abnormal Pap smear rate (Oh et al., 2009). The rate of current-smoking (6%) in the present study was similar with the rate reported in Korean women (5% at 2007) (Korea Statistical Information Service, 2011). In the current study, the percentage of women who graduated post-graduate was 14%, which is much higher than the reported 4% of all Korean women (Korea Asian Pacific Journal of Cancer Prevention, Vol 13, 2012 271

K Kim et al Statistical Information Service, 2011). In addition, the level of monthly income of women in the current study (median, 4545-7273 USD) was higher than the average monthly income of a Korean family (approximately 3000 USD). To remove the effect of age on monthly income, we compared the monthly income of women < 40 years of age with the average monthly income of a Korean family. The level of monthly income of women in the current study was higher than the average monthly income of a Korean family (data not shown). The number of children of women in the current study (median number of children, two) was similar to women in Seoul considering the median size of the family, including women, in Seoul was four people. The age at the first delivery of women in the current study was similar to that of women in Seoul. To explain further, the median age of women in the current study was 48 years and the median age at the time of first delivery was 26 years. Because the age at the time of first delivery increased with time, the median age at the time of first delivery for women in the current study was compared with that of women in Seoul in 1983 when the women in the current study had the first delivery. The mean age at the time of first delivery for women in Seoul in 1993 was 27 years, and the age at the time of first delivery in 1983 was < 27 years (Korea Statistical Information Service, 2011). The HPV prevalence in Korean women has been reported to be between 10% and 40% (Kim, 2009). The comparison of HPV prevalence between studies is difficult to perform because the age distribution and type of HPV tests were different. Therefore, we selected studies providing age-standardized prevalence and using HC2 as HPV tests. The prevalence of high-risk HPV infections in the current study was markedly lower than the rates in previous studies, including Korean women. The current study showed that the prevalence of highrisk HPV infections was 7% and the age-standardized prevalence was 8%. However, a study involving 3091 women in Seoul reported that the prevalence of highrisk HPV infections was 13% and the age-standardized prevalence was 16% (Joo et al, 2004). In another study involving 4595 women in Busan and Suwon, the prevalence of high-risk HPV infections was 8% and the age-standardized prevalence was 10% (Oh et al., 2009). The low prevalence of high-risk HPV infection in the current study could be due to the characteristics of the study population, such as high SES. Previous studies have examined the association between variables and HPV infections, and identified age, smoking, number of lifetime sex partners, alcohol consumption, age at menarche, seropositivity for herpes simplex virus type 2, extramarital affairs (husband), and vasectomy (husband) as risk factors for HPV infections (Shin et al., 2003; 2004; Joo et al., 2004; Oh et al., 2009). The current study showed that age is an important risk factor for high-risk HPV infections and has the inverse relationship with high-risk HPV infections. Similar findings were observed in many studies, including 272 Asian Pacific Journal of Cancer Prevention, Vol 13, 2012 women in the highest-income countries (Franceschi et al., 2006). The level of education and number of children were thought to be surrogate variables of age because the statistical significance of those variables on univariate analysis disappeared on multivariate analysis. In contrast to the results of previous studies (Shin et al., 2003; 2004), smoking was not associated with high-risk HPV infections in the current study. The current study had several limitations. First, this was a single center study and the study population was not randomly selected. Therefore, the extrapolation of the results of the current study was limited. Second, variables regarding sexual behavior which were associated with HPV infections in other studies were not analyzed because those data could not be obtained. Third, the detailed disease history was not available and there was the possibility that few women with a history of cervical cancer or cervical intraepithelial neoplasia were included. However, we reasoned that the large size of the current study would make the effect of those women negligible. In women with high SES in Seoul, the prevalence of high-risk HPV infections was 7% and the agestandardized prevalence was 8%. Age was a strong determinant of high-risk HPV infections. The low prevalence of high-risk HPV infections in women with high SES suggested that the public support for HPV vaccination should be focused on women with low SES. The high prevalence of high-risk HPV infections in young women supported the importance of HPV vaccination in young women. References Bae JH, Lee SJ, Kim CJ, et al (2008). Human papillomavirus (HPV) type distribution in Korean women: a metaanalysis. J Microbiol Biotechnology, 18, 788-794. Bao YP, Li N, Smith JS, et al(2008). Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecological Cancer, 18, 71-79. Bosch FX, Manos MM, Munoz N, et al(1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst, 87, 796-802. Clifford GM, Gallus S, Herrero R, et al (2005). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 366, 991-998. Clifford GM, Rana RK, Franceschi S, et al(2005). Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev, 14, 1157-1164. Clifford GM, Smith JS, Aguado T, et al(2003). Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer, 89, 101-105. Clifford GM, Smith JS, Plummer M, et al(2003). Human papillomavirus types in invasive cervical cancer

worldwide: a meta-analysis. Br J Cancer, 88, 63-73. de Villiers EM, Fauquet C, Broker TR, et al(2004). Classification of papillomaviruses. Virology, 324, 17-27. Franceschi S, Herrero R, Clifford GM, et al(2006). Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Gynecological Cancer, 119, 2677-2684. Jemal A, Bray F, Center MM, et al(2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. Joo WD, Kim SH, Kim DY, et al(2004). Prevalence of human papillomavirus infection in Korean women: risks of abnormal Pap smear and cervical neoplasia. J Gynecol Oncol, 15, 309-316. Kahn JA, Lan D, Kahn RS(2007). Sociodemographic factors associated with high-risk human papillomavirus infection. Obstetrics Gynecol, 110, 87-95. Kim YT (2009). Current status of cervical cancer and HPV infection in Korea. J Gynecol Oncol, 20, 1-7. Korea Statistical Information Service (http://www.kosis.kr/ abroad/abroad_01list.jsp?parentid=a) Accessed at 12 April, 2011. Nam K, Chung S, Kim J, et al(2009). Factors associated with HPV persistence after conization in patients with negative margins. J Gynecol Oncol, 20, 91-5. Oh JK, Franceschi S, Kim BK, et al(2009). Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea. Eur J Cancer Prev, 18, 56-61. Shin HR, Franceschi S, Vaccarella S, et al(2004). Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infectious Dis, 190, 468-76. Shin HR, Lee DH, Herrero R, et al(2003). Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer, 103, 413-21. Silva KC, Rosa ML, Moyse N, et al(2009). Risk factors associated with human papillomavirus infection in two populations from Rio de Janeiro, Brazil. Memórias do Instituto Oswaldo Cruz, 104, 885-891. Asian Pacific Journal of Cancer Prevention, Vol 13, 2012 273